Japan
· Delayed Price · Currency is JPY NANO MRNA Statistics
Total Valuation
NANO MRNA has a market cap or net worth of JPY 9.39 billion. The enterprise value is 6.41 billion.
| Market Cap | 9.39B |
| Enterprise Value | 6.41B |
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NANO MRNA has 70.60 million shares outstanding. The number of shares has increased by 0.33% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 70.60M |
| Shares Change (YoY) | +0.33% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 4.04% |
| Owned by Institutions (%) | 3.53% |
| Float | 65.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 82.37 |
| PB Ratio | 3.15 |
| P/TBV Ratio | 3.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.05 |
| EV / Sales | 56.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.23, with a Debt / Equity ratio of 0.18.
| Current Ratio | 3.23 |
| Quick Ratio | 3.09 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -19.76% and return on invested capital (ROIC) is -10.21%.
| Return on Equity (ROE) | -19.76% |
| Return on Assets (ROA) | -8.85% |
| Return on Invested Capital (ROIC) | -10.21% |
| Return on Capital Employed (ROCE) | -21.82% |
| Revenue Per Employee | 6.33M |
| Profits Per Employee | -35.44M |
| Employee Count | 18 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.70% in the last 52 weeks. The beta is 0.35, so NANO MRNA's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -25.70% |
| 50-Day Moving Average | 140.32 |
| 200-Day Moving Average | 162.94 |
| Relative Strength Index (RSI) | 47.77 |
| Average Volume (20 Days) | 1,252,580 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NANO MRNA had revenue of JPY 114.00 million and -638.00 million in losses. Loss per share was -9.05.
| Revenue | 114.00M |
| Gross Profit | 79.00M |
| Operating Income | -662.00M |
| Pretax Income | -639.00M |
| Net Income | -638.00M |
| EBITDA | n/a |
| EBIT | -662.00M |
| Loss Per Share | -9.05 |
Balance Sheet
The company has 3.52 billion in cash and 540.00 million in debt, giving a net cash position of 2.98 billion or 42.17 per share.
| Cash & Cash Equivalents | 3.52B |
| Total Debt | 540.00M |
| Net Cash | 2.98B |
| Net Cash Per Share | 42.17 |
| Equity (Book Value) | 2.98B |
| Book Value Per Share | 42.21 |
| Working Capital | 2.56B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 69.30% |
| Operating Margin | -580.70% |
| Pretax Margin | -560.53% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NANO MRNA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.33% |
| Shareholder Yield | -0.33% |
| Earnings Yield | -6.79% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 27, 2014. It was a forward split with a ratio of 100.
| Last Split Date | Mar 27, 2014 |
| Split Type | Forward |
| Split Ratio | 100 |
Scores
NANO MRNA has an Altman Z-Score of 5.62.
| Altman Z-Score | 5.62 |
| Piotroski F-Score | n/a |